Last reviewed · How we verify
An Analysis of Dermabond vs. Non-Absorbable Sutures in Skin Closure for Brow Ptosis Procedures
NA trial testing Dermabond in Brow Ptosis in 8 participants. Completed in 17 April 2024.
| Lead sponsor | Cody Blanchard |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 8 |
| Start date | 15 August 2023 |
| Primary completion | 17 April 2024 |
| Estimated completion | 17 April 2024 |
| Sites | 1 location across United States |
Cody Blanchard
Adults 18 to 100, any sex, with Brow Ptosis or Surgical Wound. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Patient and Observer Scar Assessment Scale filled out by both patient and provider at both postoperative visits of both Dermabond and non-absorbable sutures. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey.
| Group | Value | 95% CI |
|---|---|---|
| Active Comparator: Dermabond | 7 | 5 – 9 |
| Active Comparator: Non-Absorbable Sutures | 2.33 | 1 – 4 |
Patient and Observer Scar Assessment Scale filled out by both patient and provider at both postoperative visits of both Dermabond and non-absorbable sutures. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey.
| Group | Value | 95% CI |
|---|---|---|
| Active Comparator: Dermabond | 2 | 1 – 3 |
| Active Comparator: Non-Absorbable Sutures | 4 | 3 – 5 |
Complications of both Dermabond and non-absorbable sutures to include dehiscence and infection
| Group | Value | 95% CI |
|---|---|---|
| Active Comparator: Dermabond | 0 | |
| Active Comparator: Non-Absorbable Sutures | 0 |
The goal of this clinical trial is to compare Dermabond with non-absorbable sutures in skin closure after brow ptosis surgery. The main questions it aims to answer are: * if Dermabond provides equivalent wound healing compared to conventional non-absorbable skin suture techniques * if Dermabond provides equivalent scar appearance compared to conventional non-absorbable suture techniques * if Dermabond results in equivalent complication rates compared to conventional non-absorbable suture techniques Participants will have be randomly selected to have either Dermabond or non-absorbable suture closure methods. Scar analysis and both participant and provider surveys will be performed to assess the differences between groups, if any.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Trials testing the same drug.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05981443.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing